Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis

BACKGROUND: Long-acting bronchodilators are the cornerstone of pharmacologic treatment of COPD. The new combination of long-acting muscarinic antagonist (LAMA) tiotropium (TIO) and long acting beta-agonists (LABA) olodaterol (OLO) has been introduced as fist line therapy for COPD. This article analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Miravitlles, Marc, Urrutia, Gerard, Mathioudakis, Alexander G., Ancochea, Julio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702233/
https://www.ncbi.nlm.nih.gov/pubmed/29178871
http://dx.doi.org/10.1186/s12931-017-0683-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702233/
https://www.ncbi.nlm.nih.gov/pubmed/29178871
http://dx.doi.org/10.1186/s12931-017-0683-x

Ejemplares similares